Your browser doesn't support javascript.
loading
Dual inhibition of PI3K signaling and histone deacetylation halts proliferation and induces lethality in mantle cell lymphoma.
Guo, Hui; Zeng, Dongfeng; Zhang, Hui; Bell, Taylor; Yao, Jun; Liu, Yang; Huang, Shengjian; Li, Carrie J; Lorence, Elizabeth; Zhou, Shouhao; Gong, Tiejun; Jiang, Changying; Ahmed, Makhdum; Yao, Yixin; Nomie, Krystle J; Zhang, Liang; Wang, Michael.
Afiliación
  • Guo H; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Zeng D; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Zhang H; Department of Hematology, Xinqiao Hospital, The Third Military Medical University, 430000, Chongqing, China.
  • Bell T; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Yao J; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Liu Y; Department of Molecular & Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Huang S; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Li CJ; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Lorence E; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Zhou S; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Gong T; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Jiang C; Institute of Hematology & Oncology, The First Hospital of Harbin, 150010, Harbin, China.
  • Ahmed M; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Yao Y; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Nomie KJ; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Zhang L; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Wang M; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Oncogene ; 38(11): 1802-1814, 2019 03.
Article en En | MEDLINE | ID: mdl-30361685
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Pirazoles / Pirimidinas / Protocolos de Quimioterapia Combinada Antineoplásica / Morfolinas / Apoptosis / Linfoma de Células del Manto / Proliferación Celular Límite: Animals / Humans / Male Idioma: En Revista: Oncogene Asunto de la revista: BIOLOGIA MOLECULAR / NEOPLASIAS Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Pirazoles / Pirimidinas / Protocolos de Quimioterapia Combinada Antineoplásica / Morfolinas / Apoptosis / Linfoma de Células del Manto / Proliferación Celular Límite: Animals / Humans / Male Idioma: En Revista: Oncogene Asunto de la revista: BIOLOGIA MOLECULAR / NEOPLASIAS Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos